Outpatient COVID-19 Treatment
Community Hospital offers outpatient COVID-19 treatment to those at high risk of hospitalization
In late November 2020, Community Hospital was granted permission under an emergency use authorization to start monoclonal antibody treatment for those in the early stages of COVID-19 who were considered at high risk for developing severe cases of the disease. These antibody infusions are the only authorized outpatient treatment for COVID-19. Community Hospital’s Emergency department has administered monoclonal antibodies to 110 patients who fit certain criteria, such as age 65 or older or who have kidney disease, diabetes, or a body mass index of 35 or higher. Treatment is time-sensitive and can only be given within 10 days of a positive COVID-19 diagnosis.
Monoclonal antibody treatments are done through a transfusion and take about 3 hours. To date, none of those who have received treatment at Community Hospital have had adverse side effects. Of the 110 patients receiving the treatment, about 20 percent have returned for additional care in the Emergency department or have been admitted.
Community members who find out they are positive, have symptoms, and fit the high-risk criteria should contact their doctor to discuss this treatment as soon as possible. The earlier the treatment is given, the greater the success in minimizing the effects of COVID-19. Most insurance covers the cost of the treatment.
See our COVID treatment outlook